Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Isophane vs. Insulin Glargine in NODAT
NCT01963728Phase 4Terminated
- Sponsor
- Inova Health System
- Start
- Nov 2013
- Primary completion
- Apr 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin isophane in post-transplantation diabetes mellitus (PTDM) (2 arms), sponsored by Inova Health System. Primary endpoint: Change in Hemoglobin A1C at 6 months. Started Nov 2013; status: terminated.
02
Drugs
insulin isophane
03
Conditions
post-transplantation diabetes mellitus (PTDM)
Beyond the preview
Go deeper on NCT01963728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01963728.